Statins in community acquired pneumonia: Evidence from experimental and clinical studies
Authors:
- James D. ChalmersJCJames D. Chalmers
- Philip M. ShortPSPhilip M. Short
- Pallavi MandalPMPallavi Mandal
- Ahsan R. AkramAAAhsan R. Akram
- Adam T. HillAHAdam T. Hill
- 1 August 2010
- journal article
- review article
- Published by Elsevier in Respiratory Medicine
- Vol. 104 (8) , 1081-1091
Abstract
No abstract availableKeywords
This publication has 99 references indexed in Scilit:
- Simvastatin Decreases Lipopolysaccharide-induced Pulmonary Inflammation in Healthy VolunteersAmerican Journal of Respiratory and Critical Care Medicine, 2009
- Increasing Hospital Admissions for Pneumonia, EnglandEmerging Infectious Diseases, 2008
- Cross-talk Between Statins and PPARα in Cardiovascular Diseases: Clinical Evidence and Basic MechanismsTrends in Cardiovascular Medicine, 2008
- Acute Lower Respiratory Tract InfectionNew England Journal of Medicine, 2008
- Pleiotropic effects of statin therapy: molecular mechanisms and clinical resultsTrends in Molecular Medicine, 2008
- Understanding the Inflammatory Cytokine Response in Pneumonia and SepsisArchives of internal medicine (1960), 2007
- Statins and the Risk of Pneumonia: A Population‐Based, Nested Case‐Control StudyPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2007
- Clinical trials in severe sepsis with drotrecogin alfa (activated)Critical Care, 2007
- Statin treatment and reduced risk of pneumonia in patients with diabetesThorax, 2006
- Statins and outcomes in patients admitted to hospital with community acquired pneumonia: population based prospective cohort studyBMJ, 2006